Fondaparinux Sodium Injection 2.5mg/0.5ml

Deep vein thrombosis, a disorder in which risky blood clots develop in the blood arteries of the legs, is prevented by Fondaparinux Sodium Injection. The illness known as pulmonary embolism may develop as a result of these blood clots being lodged in the lungs’ blood vessels.

As prescribed by your doctor, this drug is typically injected beneath the skin of the stomach or abdomen once daily. Avoid injecting into muscles. The dosage and duration of the course of action will depend on your medical condition and how you respond to treatment. Your weight may also factor into the dosage.

A synthetic anticoagulant called fondaparinux (Arixtra) is based on the pentasaccharide sequence found in the minimum antithrombin (AT) binding region of heparin. It is an indirect inhibitor of factor Xa, much like low molecular weight heparins, although it does not affect thrombin.

• Negative effects
• Tarry, dark stools.
• a bladderache.
• blood in the stools or urine.
• chest pain
• blood staining under the skin.
• convulsions.
• pee that is less or cloudier.
• dark purple bruise.

Activated partial thromboplastin time (aPTT), activated clotting time (ACT), prothrombin time (PT)/International Normalized Ratio (INR) assays in plasma, or bleeding time are unaffected by Arixtra at a dose of 2.5 mg.

Fondaparinux Sodium Injection is injected subcutaneously for the first dose and intravenously for all future doses. Following diagnosis, treatment should begin as soon as feasible and continue for a maximum of 8 days, or until hospital release if that happens sooner.

The drug’s ability to suppress factor Xa makes it possible to monitor Fondaparinux in a laboratory setting. Using a standard curve created with Fondaparinux, the Anti-Xa test (used to monitor heparin) is adjusted within three hours after sample collection.

In patients undergoing hip surgery, hip or knee replacement surgery, or abdominal surgery, fondaparinux injection is used to avoid deep vein thrombosis (DVT; a blood clot, typically in the leg), which can result in pulmonary embolism (PE; a blood clot in the lung).

To avoid deep vein thrombosis after stomach or abdominal surgery: Adults: 2.5 mg intravenously given once each day for 5 to 9 days. 6 to 8 hours after surgery, the first dose is administered.

Check this  anticoagulant Product Enoxaparin Sodium Injection or you may explore more anticoagulants by clicking here

We are an exporter from India and work in excess countries like the UAE, Oman, Qatar, Myanmar, Saudi Arabia, Netherlands, Albania, Saint Lucia, Jordan, Romania, South Africa, etc.